BD (Becton, Dickinson and Company), a leading global medical technology company, reached a 75% reduction in GHG emissions in 2018 from a baseline year of 2008, normalized to cost of products sold, well ahead of its 2020 target of 50%. The company is close to its goal of using renewable energy to pow
Read More...
BD (Becton, Dickinson and Company) released Oct. 18 its new sustainability strategy, including a target to reach carbon neutral operations by 2040.The medical tech company identified five areas that are its highest priorities in generating change over the next decade: climate change, product i
Read More...
BD (Becton, Dickinson and Company) made progress toward its goal of 25% energy reduction by 2030 (from a 2019 baseline, normalized to cost of products sold), achieving 14% energy reduction in FY 2021, in addition to increasing its investment in on-site renewable energy. The global medical techn
Read More...